Shingrix, a recombinant zoster vaccine, combines glycoprotein E antigen with an adjuvant system called AS01B. It has been ...
European Commission approves GSK’s recombinant zoster vaccine, Shingrix in prefilled syringe: London, UK Thursday, January 8, 2026, 09:00 Hrs [IST] GSK plc announced the Europea ...
On October 21, 2025, GSK announced that the European Medicine Agency’s (“EMA”) Committee for Medicinal Products for Human Use (“CHMP”) adopted a positive opinion for the shingle vaccine SHINGRIX ...
Evidence from a team of scientists at the University of Oxford indicates that the newer shingles vaccine is more protective against dementia compared to the previous shingles vaccine. Both shingles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback